| Literature DB >> 28240870 |
Xiaoding Xu1, Jun Wu1, Yanlan Liu1, Phei Er Saw1, Wei Tao1, Mikyung Yu1, Harshal Zope1, Michelle Si1, Amanda Victorious1, Jonathan Rasmussen1, Dana Ayyash1, Omid C Farokhzad1,2, Jinjun Shi1.
Abstract
With the capability of specific silencing of target gene expression, RNA interference (RNAi) technology is emerging as a promising therapeutic modality for the treatment of cancer and other diseases. One key challenge for the clinical applications of RNAi is the safe and effective delivery of RNAi agents such as small interfering RNA (siRNA) to a particular nonliver diseased tissue (e.g., tumor) and cell type with sufficient cytosolic transport. In this work, we proposed a multifunctional envelope-type nanoparticle (NP) platform for prostate cancer (PCa)-specific in vivo siRNA delivery. A library of oligoarginine-functionalized and sharp pH-responsive polymers was synthesized and used for self-assembly with siRNA into NPs with the features of long blood circulation and pH-triggered oligoarginine-mediated endosomal membrane penetration. By further modification with ACUPA, a small molecular ligand specifically recognizing prostate-specific membrane antigen (PSMA) receptor, this envelope-type nanoplatform with multifunctional properties can efficiently target PSMA-expressing PCa cells and silence target gene expression. Systemic delivery of the siRNA NPs can efficiently silence the expression of prohibitin 1 (PHB1), which is upregulated in PCa and other cancers, and significantly inhibit PCa tumor growth. These results suggest that this multifunctional envelope-type nanoplatform could become an effective tool for PCa-specific therapy.Entities:
Keywords: membrane-penetrating; multifunctional nanoparticle; pH-responsive; prostate cancer; siRNA; targeted delivery
Mesh:
Substances:
Year: 2017 PMID: 28240870 PMCID: PMC5626580 DOI: 10.1021/acsnano.6b07195
Source DB: PubMed Journal: ACS Nano ISSN: 1936-0851 Impact factor: 15.881